Cell Therapy Strategies on Duchenne Muscular Dystrophy: A Systematic Review of Clinical Applications

被引:0
作者
Ayberk Akat
Erdal Karaöz
机构
[1] Life Park Hospital,
[2] Cellular and Biological Products Manufacturing Center,undefined
[3] Liv Hospital Ulus,undefined
[4] Regenerative Medicine and Stem Cell Center,undefined
来源
Stem Cell Reviews and Reports | 2024年 / 20卷
关键词
Duchenne Muscular Dystrophy; Cell Therapy; Clinical Trials; Regenerative Medicine;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:138 / 158
页数:20
相关论文
共 707 条
[1]  
Mercuri E(2013)Muscular dystrophies The Lancet 381 845-860
[2]  
Muntoni F(2002)The muscular dystrophies The Lancet 359 687-695
[3]  
Emery AE(2008)Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry American heart journal 155 998-1005
[4]  
Connuck DM(2013)Muscle-specific discordant skewing of X chromosome inactivation leads to different clinical phenotypes of Duchenne muscular dystrophy in two monozygotic female twins Neuropediatrics 44 FV16_04-46
[5]  
Sleeper LA(1965)Muscular dystrophy (Duchenne) in a girl with Turner's syndrome Journal of Medical Genetics 2 38-196
[6]  
Colan SD(1986)De novo DNA microdeletion in a girl with Turner syndrome and Duchenne muscular dystrophy Human Genetics 74 193-917
[7]  
Cox GF(2004)Prenatal diagnosis of DMD in a female fetus affected by Turner syndrome Prenatal Diagnosis 24 913-267
[8]  
Towbin JA(2018)Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management The Lancet. Neurology 17 251-7
[9]  
Lowe AM(2023)Duchenne muscular dystrophy: Current treatment and emerging exon skipping and gene therapy approach European Journal of Pharmacology 947 175675-e1604
[10]  
Wilkinson JD(2007)Pathophysiology of Duchenne muscular dystrophy: Current hypotheses Pediatric Neurology 36 1-1053